Overview:
Recombinant DNA technology is responsible for advancement in various fields such as agriculture, research, and drug development. This technology is effective in improving health and food resources. Recombinant DNA technology has developed new classes of organisms named as genetically modified organisms (GMO) or living modified organisms (LMO). The technology is useful in modification of crops (BT cotton), bio pesticides, cloned animals, gene therapy and biofuels. Recombinant DNA technology has encouraged development of many products based on the technology such as CAR-T cell therapy, bispecific and monoclonal antibodies, which in turn supports the growth of the global market of recombinant DNA technology.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/893
The global recombinant DNA technology market was valued at US$ 106.8 billion in 2017, and is expected to exhibit a robust CAGR of 7.9% over the forecast period (2017 – 2025).
Drivers:
Advancement in technologies accelerating production of new products based on recombinant DNA technology for treatment of fatal diseases such as diabetes, cancer and various infectious disease are expected to augment growth of the global recombinant DNA technology market. For instance, in 2017, the Global Diabetes Community reported that diabetes affects around 422 million people worldwide and the number is expected to increase to 642 million by 2040. Moreover, the World Health Organization (WHO) projected diabetes caused 1.5 million cases of mortality and high blood sugar levels caused 2.2 million deaths.
Increasing initiatives and research grants for the advancement of new therapeutics with recombinant DNA technology are expected to boost growth of the global market of recombinant DNA technology. For instance, in March 2017, the National Institute of Allergy and Infectious Diseases (NIAID) granted US$ 16.3 million to the University of Pennsylvania for the development of HIV vaccine using recombinant DNA technology
In 2015, Translational Genomics Research Institute (TGen) partnered with Baylor Research Institute (BRI) to develop customized vaccines for various diseases such as cardiovascular, infectious diseases, neurological disease and diabetes to accelerate their early detection and treatments.
Restraints:
Factors such as expensive gene therapies and side effects of the therapy such as Cytokine Release Syndrome (CRS) are expected to hamper growth of the recombinant DNA technology market. For instance, in January 2018, a survey conducted by CNBC LLC reported that the CAR-T treatment developed by Novartis costs US$ 475,000 and the treatment developed by AG and Gilead Sciences costs US $ 373,000 per patient.
Opportunities:
Key players in the market are adopting various strategies such as collaborations, mergers and acquisitions to develop new recombinant DNA technology based therapeutics, which in turn is expected to create lucrative growth opportunities for market players. For instance, in August 2017, Sanofi Pasteur announced the acquisition of Protein Sciences. The acquisition made addition of Flublok (Influenza Vaccine) to Sanofi Pasteur’s vaccine portfolio.
In 2014, Pfizer, Inc. collaborated with the Massachusetts Institute of Technology (MIT) for technological development using recombinant DNA technology and to advance drug discovery to transform treatment of various diseases.
Key players:
Key players active in the global recombinant DNA technology market include Biogen, Inc., Merck & Co., Inc., Profacgen, Monsanto Company. Thermo Fisher Scientific, Inc., Sanofi Pasteur, Pfizer, Inc., and Amgen, Inc.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/893
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Industry Trends
- Regulatory Scenario
- Key Highlights
- PEST Analysis
- Epidemiology
- Impact Analysis
- PORTER’s Analysis
- Market Dynamics
- Global Recombinant DNA Technology Market, By Product Type, 2015 – 2025, (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Recombinant Protein Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Segment Trends
- Insulin
- Human Growth Hormone
- Erythropoietin
- Interferon
- Blood Factors
- Colony Stimulating Factors
- Fusion Proteins
- Others
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Genetically Modified Crops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Expression Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Segment Trends
- Prokaryotic Cells
- Mammalian Cells
- Yeats
- Insect
- Others
- Cell and Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Gene Editing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Introduction
- Global Recombinant DNA Technology Market, By Application, 2015 – 2025, (US$ Billion)
- Introduction
- Market Share Analysis, 2015 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Agriculture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
- Introduction
- Global Recombinant DNA Technology Market, By Region, 2015 – 2025, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2015 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- North America
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
- South Africa
- Central Africa
- North Africa
- Introduction
Press Release: https://www.coherentmarketinsights.com/press-release/recombinant-dna-technology-market-to-surpass-us-1967-billion-by-2025-376
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837